- BTSG Dashboard
- Filings
- Insider
-
Article
Goldman Sachs Maintains Buy on BrightSpring Health, Lowers Price Target to $23
Company Profile
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.